Evaluation of the clinical utility of Cobas TaqMan HCV v2.0
The correlation and sensitivity of TaqMan HCV v1.0 (v.1.0) and TaqMan HCV v2.0 (v.2.0) were evaluated by using 239 clinical specimens from 40 patients undergoing Telaprevir-based triple therapy. A correlation study was performed with the specimens from patients at baseline, day 1 and day 3 of the th...
Saved in:
Published in | Kanzo Vol. 56; no. 1; pp. 21 - 23 |
---|---|
Main Authors | , , , , , , , , , , , , , , |
Format | Journal Article |
Language | Japanese English |
Published |
The Japan Society of Hepatology
2015
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!